M5049
MS200569_0026
Phase 2 small_molecule completed
Quick answer
M5049 for Coronavirus Disease 2019 is a Phase 2 program (small_molecule) at Serono Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Serono Europe Limited
- Indication
- Coronavirus Disease 2019
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed